CIP2A and cervical carcinoma: The data strongly indicated that only CIP2A (but not PP2A or c-MYC) is a reliable biomarker for detection of cervical cancer and furthermore there was no strong correlation of CIP2A expression with HPV subtype, age, ethnical background, or other patient characteristics.